Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
出版年份 2019 全文链接
标题
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
作者
关键词
-
出版物
Nature Communications
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-03-22
DOI
10.1038/s41467-019-09307-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
- (2019) Arnaud Scherpereel et al. LANCET ONCOLOGY
- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
- (2018) Jorien Minnema-Luiting et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel therapies for malignant pleural mesothelioma
- (2018) Arnaud Scherpereel et al. LANCET ONCOLOGY
- Axl inhibitors as novel cancer therapeutic agents
- (2018) Yingying Shen et al. LIFE SCIENCES
- MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma
- (2018) Lorenzo Nicolè et al. Oncotarget
- Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
- (2018) Derek B. Oien et al. Frontiers in Pharmacology
- Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
- (2018) Vasiliki Gkretsi et al. Frontiers in Oncology
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- (2018) Julija Hmeljak et al. Cancer Discovery
- Targeting YAP in malignant pleural mesothelioma
- (2017) Wen-Qian Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
- (2017) Yankun Liu et al. Cell Death & Disease
- The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
- (2017) José M. García-Heredia et al. Oncotarget
- Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
- (2017) Walter Blum et al. Stem Cell Reports
- Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
- (2017) Marius Ilie et al. PLoS One
- Novel Insights into the Roles of Rho Kinase in Cancer
- (2016) Lei Wei et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma
- (2016) Robin Tranchant et al. CLINICAL CANCER RESEARCH
- Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
- (2016) Etienne Becht et al. CLINICAL CANCER RESEARCH
- Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
- (2016) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Targeting WEE1 Kinase in Cancer
- (2016) Christopher J. Matheson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Predicting tumor purity from methylation microarray data
- (2015) Naiqian Zhang et al. BIOINFORMATICS
- ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels
- (2015) S Rondeau et al. BRITISH JOURNAL OF CANCER
- The Role of miR-21 in Cancer
- (2015) Susan R. Pfeffer et al. DRUG DEVELOPMENT RESEARCH
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
- (2015) Chih-Hung Chou et al. NUCLEIC ACIDS RESEARCH
- Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition
- (2014) Aurélien de Reyniès et al. CLINICAL CANCER RESEARCH
- Tumour-suppressivemicroRNA-24-1inhibits cancer cell proliferation through targetingFOXM1in bladder cancer
- (2014) Satoru Inoguchi et al. FEBS LETTERS
- DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions
- (2014) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy
- (2014) J. L. Lines et al. Cancer Immunology Research
- Role of the complement system in NK cell-mediated antitumor T-cell responses
- (2014) Valérie Janelle et al. OncoImmunology
- MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells
- (2013) Jipeng Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment
- (2012) Didier Jean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Immunohistochemistry and Molecular Diagnostics of Pleural Malignant Mesothelioma
- (2012) Pier-Giacomo Betta et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases
- (2011) Sarah X. L. Huang et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
- (2011) J. M. Kreahling et al. MOLECULAR CANCER THERAPEUTICS
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments
- (2010) James H Bullard et al. BMC BIOINFORMATICS
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
- (2010) H. I. Pass et al. CANCER RESEARCH
- Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
- (2008) B. C. Christensen et al. CANCER RESEARCH
- The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
- (2008) Qihong Huang et al. NATURE CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started